Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T22:33:29.816Z.
Calculation as of: 2026-10-06T22:33:29.816Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8f998ac52bf92492c18c8c1a056427339c5b213780e3da80cf9ae2163b61907c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2021-08-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Treace Medical Concepts, Inc.
Market Cap
$259.49M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$259.56M
EV/EBIT Ratio
N/A
TTM Avg
5.32x
3Y Avg
26.78x
5Y Avg
44.78x
Market Cap
$259.14M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$259.12M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$258.63M
EV/EBIT Ratio
N/A
TTM Avg
162862.62x
3Y Avg
112489.16x
5Y Avg
112489.16x
Market Cap
$261.43M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$262.92M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Treace Medical Concepts, Inc. (TMCI) | $259.49M | N/A | N/A | N/A | N/A |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | N/A | 5.32x | 26.78x | 44.78x |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.14M | N/A | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $259.12M | N/A | N/A | N/A | N/A |
| Palisade Bio, Inc. (PALI)vs › | $258.63M | N/A | 162862.62x | 112489.16x | 112489.16x |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | N/A | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | N/A | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $256.47M | N/A | 17.57x | 14.15x | 16.75x |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | N/A | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | N/A | 6.80x | 6.80x | 39.86x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2021-08-05 | 2196.36x |
| 2021-08-04 | 2195.59x |
| 2021-08-03 | 2284.60x |
| 2021-08-02 | 2334.13x |
| 2021-07-30 | 2361.99x |
| 2021-07-29 | 2273.76x |
| 2021-07-28 | 2246.67x |
| 2021-07-27 | 2156.89x |
| 2021-07-26 | 2112.00x |
| 2021-07-23 | 2115.10x |
| 2021-07-22 | 2135.99x |
| 2021-07-21 | 2205.65x |
| 2021-07-20 | 2166.95x |
| 2021-07-19 | 2148.38x |
| 2021-07-16 | 2163.08x |
| 2021-07-15 | 2130.58x |
| 2021-07-14 | 2176.24x |
| 2021-07-13 | 2251.31x |
| 2021-07-12 | 2267.57x |
| 2021-07-09 | 2220.36x |
| 2021-07-08 | 2296.20x |
| 2021-07-07 | 2361.22x |
| 2021-07-06 | 2266.02x |
| 2021-07-02 | 2341.87x |
| 2021-07-01 | 2380.57x |
| 2021-06-30 | 2439.39x |
| 2021-06-29 | 2379.02x |
| 2021-06-28 | 2478.86x |
| 2021-06-25 | 2419.27x |
| 2021-06-24 | 2457.96x |
| 2021-06-23 | 2552.39x |
| 2021-06-22 | 2635.20x |
| 2021-06-21 | 2611.21x |
| 2021-06-18 | 2613.53x |
| 2021-06-17 | 2712.60x |
| 2021-06-16 | 2764.46x |
| 2021-06-15 | 2720.34x |
| 2021-06-14 | 2681.64x |
| 2021-06-11 | 2814.76x |
| 2021-06-10 | 2776.07x |
| 2021-06-09 | 2776.07x |
| 2021-06-08 | 2802.38x |
| 2021-06-07 | 2718.02x |
| 2021-06-04 | 2807.80x |
| 2021-06-03 | 2805.48x |
| 2021-06-02 | 2779.16x |
| 2021-06-01 | 2648.36x |
| 2021-05-28 | 2531.49x |
| 2021-05-27 | 2522.20x |
| 2021-05-26 | 2308.59x |
| 2021-05-25 | 1672.98x |
| 2021-05-24 | 1681.83x |
| 2021-05-21 | 1713.11x |
| 2021-05-20 | 1753.84x |
| 2021-05-19 | 1776.27x |
| 2021-05-18 | 1807.55x |
| 2021-05-17 | 1747.94x |
| 2021-05-14 | 1752.66x |
| 2021-05-13 | 1612.19x |
| 2021-05-12 | 1845.91x |
| 2021-05-11 | 1962.18x |
| 2021-05-10 | 1961.00x |
| 2021-05-07 | 1937.39x |
| 2021-05-06 | 1791.61x |
| 2021-05-05 | 1807.55x |
| 2021-05-04 | 1696.00x |
| 2021-05-03 | 1795.15x |
| 2021-04-30 | 1865.98x |
| 2021-04-29 | 1745.58x |
| 2021-04-28 | 1726.69x |
| 2021-04-27 | 1860.67x |
| 2021-04-26 | 1723.15x |
| 2021-04-23 | 1521.89x |
